Smart Diabetes Management Market

Smart Diabetes Management Market (Product: Devices and Apps & Software; Application: Type 1 Diabetes and Type 2 Diabetes: End User: Self/Home Healthcare and Hospital/ Specialty Diabetes Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Rep Id : TMRGL69717
  • Published On : Jul 2019
  • No. of Pages : 172
  • Category : Healthcare

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Smart Diabetes Management Market 
4. Market Overview

    4.1. Introduction
        4.1.1. Products Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
            4.3.1.1. Rise in prevalence of diabetes
            4.3.1.2. Increase in awareness about diabetes
            4.3.1.3. Favourable reimbursement policies
            4.3.1.4. Surge in adoption of connected medical devices
        4.3.2. Restraints
            4.3.2.1. High cost
            4.3.2.2. Patient and provider burden
            4.3.2.3. Patient privacy & data security
        4.3.3. Opportunities
    4.4. Global Smart Diabetes Management Market Analysis and Forecast, 2019–2027
5. Market Outlook
    5.1. Technological Advancement
    5.2. Key Development (Product launch, Approval, Collaboration, Partnership, and Acquisitions)
    5.3. Diabetes Prevalence in Key Countries 
6. Global Smart Diabetes Management Market Analysis and Forecast, By Products 
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Global Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        6.3.1. Devices 
            6.3.1.1. Smart Glucose Meters
            6.3.1.2. Continuous Glucose Monitoring Systems
            6.3.1.3. Smart Insulin Pens
            6.3.1.4. Smart Insulin Pumps
            6.3.1.5. Closed Loop Systems
        6.3.2. Apps & Software
    6.4. Global Smart Diabetes Management Market Attractiveness, by Product 
7. Global Smart Diabetes Management Market Analysis and Forecast, by Application 
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Global Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        7.3.1. Type 1 Diabetes 
        7.3.2. Type 2 Diabetes 
    7.4. Global Smart Diabetes Management Market Attractiveness, by Application 
8. Global Smart Diabetes Management Market Analysis and Forecast, by End-user 
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Global Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        8.3.1. Self/Home Healthcare
        8.3.2. Hospital/Specialty Diabetes Clinics
    8.4. Global Smart Diabetes Management Market Attractiveness, by End-user 
9. Global Smart Diabetes Management Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Global Smart Diabetes Management Market Value Forecast, by Region
        9.2.1. North America 
        9.2.2. Europe 
        9.2.3. Asia Pacific 
        9.2.4. Latin America 
        9.2.5. Middle East & Africa 
    9.3. Global Smart Diabetes Management Market Attractiveness, by Region
10. North America Smart Diabetes Management Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. North America Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        10.2.1. Devices 
            10.2.1.1. Smart Glucose Meters
            10.2.1.2. Continuous Glucose Monitoring Systems
            10.2.1.3. Smart Insulin Pens
            10.2.1.4. Smart Insulin Pumps
            10.2.1.5. Closed Loop Systems
        10.2.2. Apps & Software
    10.3. North America Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        10.3.1. Type 1 Diabetes 
        10.3.2. Type 2 Diabetes 
    10.4. North America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        10.4.1. Self/Home Healthcare
        10.4.2. Hospital/Specialty Diabetes Clinics
    10.5. North America Smart Diabetes Management Market Value Forecast, by Country, 2019–2027
        10.5.1. U.S.
        10.5.2. Canada
    10.6. North America Smart Diabetes Management Market Attractiveness Analysis 
        10.6.1. By Products 
        10.6.2. By Application 
        10.6.3. By End-user 
        10.6.4. By Country
11. Europe Smart Diabetes Management Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Europe Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        11.2.1. Devices 
            11.2.1.1. Smart Glucose Meters
            11.2.1.2. Continuous Glucose Monitoring Systems
            11.2.1.3. Smart Insulin Pens
            11.2.1.4. Smart Insulin Pumps
            11.2.1.5. Closed Loop Systems
        11.2.2. Apps & Software
    11.3. Europe Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        11.3.1. Type 1 Diabetes 
        11.3.2. Type 2 Diabetes 
    11.4. Europe Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        11.4.1. Self/Home Healthcare
        11.4.2. Hospital/Specialty Diabetes Clinics
    11.5. Europe Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Europe Smart Diabetes Management Market Attractiveness Analysis 
        11.6.1. By Products 
        11.6.2. By Application 
        11.6.3. By End-user 
        11.6.4. By Country/Sub-region
12. Asia Pacific Smart Diabetes Management Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Asia Pacific Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        12.2.1. Devices 
            12.2.1.1. Smart Glucose Meters
            12.2.1.2. Continuous Glucose Monitoring Systems
            12.2.1.3. Smart Insulin Pens
            12.2.1.4. Smart Insulin Pumps
            12.2.1.5. Closed Loop Systems
        12.2.2. Apps & Software
    12.3. Asia Pacific Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        12.3.1. Type 1 Diabetes 
        12.3.2. Type 2 Diabetes 
    12.4. Asia Pacific Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        12.4.1. Self/Home Healthcare
        12.4.2. Hospital/Specialty Diabetes Clinics
    12.5. Asia Pacific Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Asia Pacific Smart Diabetes Management Market Attractiveness Analysis 
        12.6.1. By Products 
        12.6.2. By Application 
        12.6.3. By End-user 
        12.6.4. By Country/Sub-region
13. Latin America Smart Diabetes Management Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Latin America Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        13.2.1. Devices 
            13.2.1.1. Smart Glucose Meters
            13.2.1.2. Continuous Glucose Monitoring Systems
            13.2.1.3. Smart Insulin Pens
            13.2.1.4. Smart Insulin Pumps
            13.2.1.5. Closed Loop Systems
        13.2.2. Apps & Software
    13.3. Latin America Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        13.3.1. Type 1 Diabetes 
        13.3.2. Type 2 Diabetes 
    13.4. Latin America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        13.4.1. Self/Home Healthcare
        13.4.2. Hospital/Specialty Diabetes Clinics
    13.5. Latin America Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Latin America Smart Diabetes Management Market Attractiveness Analysis 
        13.6.1. By Product 
        13.6.2. By Application 
        13.6.3. By End-user 
        13.6.4. By Country/Sub-region
14. Middle East & Africa Smart Diabetes Management Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        14.2.1. Devices 
            14.2.1.1. Smart Glucose Meters
            14.2.1.2. Continuous Glucose Monitoring Systems
            14.2.1.3. Smart Insulin Pens
            14.2.1.4. Smart Insulin Pumps
            14.2.1.5. Closed Loop Systems
        14.2.2. Apps & Software
    14.3. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        14.3.1. Type 1 Diabetes 
        14.3.2. Type 2 Diabetes 
    14.4. Middle East & Africa Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        14.4.1. Self/Home Healthcare
        14.4.2. Hospital/Specialty Diabetes Clinics
    14.5. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis 
        14.6.1. By Products 
        14.6.2. By Application 
        14.6.3. By End-user 
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of companies)
    15.2. Market Share Analysis By Company (2018)
    15.3. Company Profiles
        15.3.1. F. Hoffmann-La Roche Ltd 
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Medtronic
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Dexcom, Inc
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Insulet Corporation 
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Abbott
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Jiangsu Delfu medical device Co., Ltd 
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
        15.3.7. DIAMESCO CO., Ltd.
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
        15.3.8. LifeScan, Inc. 
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Strategic Overview
        15.3.9. Glooko, Inc.
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Strategic Overview
        15.3.10. GlucoMe
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Strategic Overview

List of Tables

Table 01: New Product Launch & FDA Approvals
Table 02: New Product Launch & FDA Approvals
Table 03: New Product Launch & FDA Approvals
Table 04: Key Development (Collaboration, Partnership, Merger & Acquisition)
Table 05: Key Development (Collaboration, Partnership, Merger & Acquisition)
Table 06: Diabetes Prevalence in Key Countries 
Table 07: Diabetes Prevalence in Key Countries
Table 08: Diabetes Prevalence in Key Countries
Table 09: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 10: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 11: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 13: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 14: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 16: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 17: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 18: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 19: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 21: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 23: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 25: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 26: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 27: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 28: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 29: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 30: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 31: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 32: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 33: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 34: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 35: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 36: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 37: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 38: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global Smart Diabetes Management Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Smart Diabetes Management Market Value (US$ Mn), by Product, 2018
Figure 03: Market Snapshot - Top 2 Trends
Figure 04: Market Overview
Figure 05: Global Smart Diabetes Management Market Value Share, by Product, 2018
Figure 06: Global Smart Diabetes Management Market Value Share, by Application, 2018
Figure 07: Global Smart Diabetes Management Value Share, by End-user, 2018
Figure 08: Global Smart Diabetes Management Market Value Share, by Region, 2018
Figure 09: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, 2017–2027
Figure 10: Global Smart Diabetes Management Market Share Analysis, by Product, 2018 and 2027
Figure 11: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Devices, 2017–2027
Figure 12: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Apps & Software, 2017–2027
Figure 13: Global Smart Diabetes Management Market Attractiveness Analysis, by Product, 2018–2026
Figure 14: Global Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 15: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Type 1 Diabetes, 2017–2027
Figure 16: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Type 2 Diabetes, 2017–2027
Figure 17: Global Smart Diabetes Management Market Attractiveness Analysis, by Application, 2018–2026
Figure 18: Global Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 19: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Self/Home Healthcare, 2017–2027
Figure 20: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Hospital/Specialty Diabetes Clinics, 2017–2027
Figure 21: Global Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2018–2027
Figure 22: Global Smart Diabetes Management Market Value Share Analysis, by Region, 2018 and 2027
Figure 23: Global Smart Diabetes Management Market Attractiveness Analysis, by Region, 2018–2026
Figure 24: North America Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 25: North America Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 26: North America Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 27: North America Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 28: North America Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 29: North America Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 30: North America Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 31: North America Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 32: North America Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 33: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 34: Europe Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 35: Europe Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 36: Europe Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 37: Europe Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 38: Europe Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 39: Europe Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 40: Europe Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 41: Europe Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 42: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 43: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 44: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 45: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 46: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 47: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 48: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 49: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 51: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 52: Latin America Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 53: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 54: Latin America Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 55: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 56: Latin America Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 57: Latin America Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 58: Latin America Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 59: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 60: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 61: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 62: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 63: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 64: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 65: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 66: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 67: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 68: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 69: F. Hoffmann-La Roche Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: F. Hoffmann-La Roche Ltd Breakdown of Net Sales (%) of Diabetes Care Sub-segment, by Region, 2018
Figure 71: F. Hoffmann-La Roche Ltd Breakdown of Net Sales (%), by Diagnostics Division, 2018
Figure 72: F. Hoffmann-La Roche Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: Medtronic Breakdown of Net Sales (%), by Geography, 2018
Figure 75: Medtronic Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 77: Dexcom, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 78: Dexcom, Inc. Breakdown of Net Sales (%), by Geography, 2017
Figure 79: Dexcom, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 80: Insulet Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 81: Insulet Corporation Breakdown of Net Sales (%), by Geography, 2017
Figure 82: Insulet Corporation Breakdown of Net Sales (%), by Business Segment, 2017
Figure 83: Insulet Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 84: Abbott Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 85: Abbott Breakdown of Net Sales (%), by Country, 2018
Figure 86: Abbott Breakdown of Net Sales (%), by Business Segment, 2018
Figure 87: Abbott R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

.